Heavy users show higher psychosis risk, especially with early onset

Cannabis use patterns and psychotic-like experiences: a cross-sectional study of heavy users, occasional users, and non-users.

Journal of psychiatric research • • Moderately Relevant
🤖

AI Summary

This cross-sectional study examined 150 participants across three groups—heavy users, occasional users, and non-users—to investigate how different cannabis consumption patterns relate to psychotic-like experiences (PLEs). Using standardized assessment scales, researchers found that heavy cannabis users showed significantly elevated scores on positive symptoms (38.4 vs. 28.6 for occasional users and 18.2 for non-users), along with elevated depressive symptoms. The study also revealed a strong dose-response relationship: in heavy users, frequency of cannabis use correlated strongly with both positive symptoms (r=0.58) and depressive symptoms (r=0.52), suggesting that more frequent use is associated with greater psychological impact.

A particularly important finding was the role of early onset of cannabis use (before age 16.4), which correlated with increased PLEs and poorer overall functioning. Interestingly, negative symptoms—such as social withdrawal and emotional flatness—did not differ significantly across the three groups, suggesting that cannabis may selectively affect certain aspects of psychotic-like experiences rather than all symptoms equally. These results highlight that the psychological risks associated with cannabis are not uniform across all users; rather, they depend heavily on consumption frequency and age of first use.

The findings have practical implications for cannabis users and public health discussions. The strong association between heavy, frequent use and psychotic-like symptoms suggests that occasional cannabis use carries notably lower risk than heavy use patterns. Additionally, the elevated risk for early-onset users indicates that adolescent and young adult cannabis use may warrant particular caution, as young brains may be more vulnerable to these effects. The researchers emphasize that understanding these consumption patterns is essential for developing targeted harm reduction strategies and informed public health guidance.

📄 Original Abstract

The relationship between cannabis use and psychotic-like experiences (PLEs) remains a crucial area of investigation, particularly regarding different consumption patterns. This cross-sectional study examined 150 participants divided into three groups: heavy cannabis users (n = 43), occasional users (n = 47), and non-users (n = 60). Participants were classified using CUDIT-R scores combined with self-reported frequency of use. Assessments included the Community Assessment of Psychic Experiences (CAPE) scale, Global Assessment of Functioning (GAF), and Clinical Global Impression (CGI) scales. Cannabis use patterns, age of onset, and duration were documented. Heavy users (mean age 23.6 ± 4.9 years) showed significantly higher scores on positive symptoms (38.4 ± 6.2) compared to occasional users (28.6 ± 5.4) and non-users (18.2 ± 4.2; p < 0.01; η2p = 0.24). Depressive symptoms were also elevated in heavy users (18.6 ± 3.8) versus occasional users (15.4 ± 3.2) and non-users (12.2 ± 2.8; p < 0.01; η2p = 0.19). No significant differences were found in negative symptoms across groups (p = 0.24; η2p = 0.02). Earlier age of onset (<16.4 years) correlated with increased PLEs (r = 0.27, p < 0.05) and poorer functioning. Heavy users demonstrated strong correlations between cannabis use frequency and both positive symptoms (r = 0.58, p < 0.01) and depressive symptoms (r = 0.52, p < 0.01). The findings suggest a frequency-related association between cannabis use and PLEs, particularly for positive and depressive symptoms. Early onset of use appears to be a significant risk factor for developing psychotic-like experiences, while negative symptoms remain largely unaffected. These results highlight the importance of considering consumption patterns when assessing the psychological impact of cannabis use.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.